Search for other papers by Jeppe Lerche la Cour in
Google Scholar
PubMed
Search for other papers by Line Tang Møllehave in
Google Scholar
PubMed
Search for other papers by Bjarke Røssner Medici in
Google Scholar
PubMed
Search for other papers by Christian Zinck Jensen in
Google Scholar
PubMed
Search for other papers by Anne Ahrendt Bjerregaard in
Google Scholar
PubMed
Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
Search for other papers by Birte Nygaard in
Google Scholar
PubMed
Introduction
High compared with low educational level increases the odds of starting levothyroxine (L-T4) with a normal thyroid-stimulating hormone – the mechanism is most likely patient request. The use of liothyronine (L-T3) and desiccated thyroid extract (DTE) is also speculated to be initiated at patients’ request. Therefore, the primary aim of this study was to evaluate if educational level influences treatment with L-T3 and DTE.
Material and methods
In this register-based cross-sectional study, we included all Danish citizens ≥30 years with redeemed prescription of L-T4, L-T3, or DTE during 2017–2020. We defined educational levels as short, medium, and long (<10 years, 10–12 years, and above 12 years, respectively). The association between educational level and treatment with LT3 or DTE vs only LT4 was analyzed in logistic regression models adjusted for age and sex.
Results
We included 154,360 individuals using thyroid medication of whom 3829 were treated with L-T3 (2.48%) and 430 with DTE (0.28%). The usage was highest among women (3.15%) and the age group 40–49 (5.6%). Longer education compared with short increased the odds of being treated with DTE or L-T3 (medium education odds ratio (OR) 1.61 (95% CI 1.50–1.8) and long education OR 1.95 (95% CI 1.79–2.13)). Test for trend: OR: 1.37 (95% CI 1.31–1.42). Adjustment for other covariates did not affect the results substantially.
Conclusion
Persons with a longer compared to a shorter education are more often treated with either DTE or L-T3, and the usage of these drugs is limited to less than 3% of thyroid hormone users.
Search for other papers by Ladan Mehran in
Google Scholar
PubMed
Search for other papers by Atieh Amouzegar in
Google Scholar
PubMed
Search for other papers by Hengameh Abdi in
Google Scholar
PubMed
Search for other papers by Negar Delbari in
Google Scholar
PubMed
Department of Epidemiology and Biostatistics, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran
Search for other papers by Elham Madreseh in
Google Scholar
PubMed
Search for other papers by Maryam Tohidi in
Google Scholar
PubMed
Search for other papers by Mohammad Ali Mansournia in
Google Scholar
PubMed
Search for other papers by Fereidoun Azizi in
Google Scholar
PubMed
individuals with and without MetS as well as evaluating the incidence of TD and trend of thyroid hormones according to the MetS group, during a 10 year follow-up in an iodine sufficient population. Materials and Methods Study Design TTS is a
Department of Pediatric Endocrinology, Faculty of Medicine, Istinye University, Istanbul, Turkey
Search for other papers by Cengiz Kara in
Google Scholar
PubMed
Search for other papers by Jamala Mammadova in
Google Scholar
PubMed
Department of Medical Genetics, Faculty of Medicine, Ondokuz Mayis University, Samsun, Turkey
Search for other papers by Ümmet Abur in
Google Scholar
PubMed
Department of Medical Genetics, Faculty of Medicine, Ondokuz Mayis University, Samsun, Turkey
Search for other papers by Cagri Gumuskaptan in
Google Scholar
PubMed
Search for other papers by Elif İzci Güllü in
Google Scholar
PubMed
Search for other papers by Ayhan Dağdemir in
Google Scholar
PubMed
Search for other papers by Murat Aydın in
Google Scholar
PubMed
Introduction Primary congenital hypothyroidism (CH) is the most common endocrine disorder in newborns, with an incidence ranging from 1/1000 to 1/3000 worldwide ( 1 ). The incidence of CH has doubled over the last two decades largely due to
Amsterdam Gastroenterology Endocrinology Metabolism, Amsterdam, The Netherlands
Amsterdam Reproduction & Development Research Institute, Amsterdam, The Netherlands
Search for other papers by Anita Boelen in
Google Scholar
PubMed
Department of Pediatric Endocrinology, Emma Children’s Hospital, Amsterdam UMC, location University of Amsterdam, Amsterdam, The Netherlands
Search for other papers by Nitash Zwaveling-Soonawala in
Google Scholar
PubMed
Amsterdam Gastroenterology Endocrinology Metabolism, Amsterdam, The Netherlands
Amsterdam Reproduction & Development Research Institute, Amsterdam, The Netherlands
Endocrine Laboratory, Department of Laboratory Medicine, Amsterdam UMC, location Vrije Universiteit Amsterdam, Amsterdam, The Netherlands
Search for other papers by Annemieke C Heijboer in
Google Scholar
PubMed
Department of Pediatric Endocrinology, Emma Children’s Hospital, Amsterdam UMC, location University of Amsterdam, Amsterdam, The Netherlands
Search for other papers by A S Paul van Trotsenburg in
Google Scholar
PubMed
incidence of primary CH in the Netherlands compared to other countries ( 11 ). The current three-step T4-reflex TSH-reflexTBG NBS program also led to an improved detection of central CH with an incidence of 1:16,404 that appeared much higher than reported in
Search for other papers by Paolo Cavarzere in
Google Scholar
PubMed
Search for other papers by Laura Palma in
Google Scholar
PubMed
Search for other papers by Lara Nicolussi Principe in
Google Scholar
PubMed
Regional Center for Newborn Screening, Diagnosis and Treatment of Congenital Metabolic and Endocrinological Diseases, Verona, Italy
Search for other papers by Monica Vincenzi in
Google Scholar
PubMed
Search for other papers by Silvana Lauriola in
Google Scholar
PubMed
Pediatric Section, Department Surgical Sciences, Dentistry, Gynecology and Pediatrics, University of Verona, Verona, Italy
Search for other papers by Rossella Gaudino in
Google Scholar
PubMed
Search for other papers by Virginia Murri in
Google Scholar
PubMed
Search for other papers by Luigi Lubrano in
Google Scholar
PubMed
Search for other papers by Giuliana Rossi in
Google Scholar
PubMed
Search for other papers by Alessia Sallemi in
Google Scholar
PubMed
Search for other papers by Ermanna Fattori in
Google Scholar
PubMed
Regional Center for Newborn Screening, Diagnosis and Treatment of Congenital Metabolic and Endocrinological Diseases, Verona, Italy
Search for other papers by Marta Camilot in
Google Scholar
PubMed
Pediatric Section, Department Surgical Sciences, Dentistry, Gynecology and Pediatrics, University of Verona, Verona, Italy
Regional Center for the Diagnosis and Treatment of Children and Adolescents Rare Skeletal Disorders, Pediatric Clinic, Department of Surgical Sciences, Dentistry, Gynecology and Pediatrics, University of Verona, Verona, Italy
Search for other papers by Franco Antoniazzi in
Google Scholar
PubMed
fetus ( 3 , 4 ). The incidence of gestational hypothyroidism widely varies from 0.14 to 11.1% in different studies ( 5 , 6 , 7 ). During pregnancy, the most frequent cause of maternal hypothyroidism is autoimmunity, defined by the presence of maternal
Laboratorio 6, Departamento de Farmacobiología, Centro de Investigación y de Estudios Avanzados-Instituto Politécnico Nacional, Delegación Tlalpan, Ciudad de México, México
Search for other papers by Jorge Alberto Tapia-Martínez in
Google Scholar
PubMed
Search for other papers by Margarita Franco-Colín in
Google Scholar
PubMed
Search for other papers by Vanessa Blas-Valdivia in
Google Scholar
PubMed
Search for other papers by Edgar Cano-Europa in
Google Scholar
PubMed
development of insulin resistance, dyslipidemia, and cardiovascular complications observed in the context of obesity ( 39 ). This could explain the increase in the incidence of T2D in developing countries like Mexico with a high poverty and marginalization
Department of Clinical Research, University of Southern Denmark, Odense, Denmark
Search for other papers by Kamilla R Riis in
Google Scholar
PubMed
Department of Clinical Research, University of Southern Denmark, Odense, Denmark
Search for other papers by Camilla B Larsen in
Google Scholar
PubMed
Search for other papers by Bjarke R Medici in
Google Scholar
PubMed
Search for other papers by Christian Z Jensen in
Google Scholar
PubMed
Search for other papers by Kristian H Winther in
Google Scholar
PubMed
Search for other papers by Emil L Larsen in
Google Scholar
PubMed
Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
Department of Data and Data Support, Region Zealand, Sorø, Denmark
Search for other papers by Christina Ellervik in
Google Scholar
PubMed
Search for other papers by Jeppe L la Cour in
Google Scholar
PubMed
Department of Clinical Research, University of Southern Denmark, Odense, Denmark
Search for other papers by Laszlo Hegedüs in
Google Scholar
PubMed
Search for other papers by Thomas H Brix in
Google Scholar
PubMed
Faculty of Health Science, University of Copenhagen, Copenhagen, Denmark
Department of Cardiology, University Hospital Nordsjælland, Hillerød, Denmark
Search for other papers by Henrik E Poulsen in
Google Scholar
PubMed
Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
Steno Diabetes Center Copenhagen, Herlev, Denmark
Center for Clinical Metabolic Research, Gentofte Hospital, University of Copenhagen, Hellerup, Denmark
Search for other papers by Filip K Knop in
Google Scholar
PubMed
Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
Search for other papers by Birte Nygaard in
Google Scholar
PubMed
Department of Clinical Research, University of Southern Denmark, Odense, Denmark
Search for other papers by Steen J Bonnema in
Google Scholar
PubMed
1 Madariaga AG Santos Palacios S Guillén-Grima F & Galofré JC . The incidence and prevalence of thyroid dysfunction in Europe: a meta-analysis . Journal of Clinical Endocrinology and Metabolism 2014 99 923 – 931 . ( https://doi.org/10
Search for other papers by Irene Campi in
Google Scholar
PubMed
Search for other papers by Marco Dell’Acqua in
Google Scholar
PubMed
Search for other papers by Elisa Stellaria Grassi in
Google Scholar
PubMed
Search for other papers by Maria Cristina Vigone in
Google Scholar
PubMed
Department of Medical Biotechnology and Translational Medicine, University of Milan, Milan, Italy
Search for other papers by Luca Persani in
Google Scholar
PubMed
largest prospective study in the UK found a 0.4% incidence of antibodies interfering with TSH assay, meaning ~50,000 tests every year in the whole country ( 18 ). However, the prevalence of spurious hyperthyrotropinemia is variable, depending on the assay
Search for other papers by Arjun Rajendran in
Google Scholar
PubMed
Search for other papers by Nisha Bhavani in
Google Scholar
PubMed
Search for other papers by Vasantha Nair in
Google Scholar
PubMed
Search for other papers by Praveen V. Pavithran in
Google Scholar
PubMed
Search for other papers by V. Usha Menon in
Google Scholar
PubMed
Search for other papers by Harish Kumar in
Google Scholar
PubMed
with severe hypothyroidism appeared to have died in coma. Since then, around 300 cases have been reported in the literature [ 1 ], with the reported incidence rate being around 0.22 per million per year [ 2 ]. The diagnosis of myxedema coma is usually
Pediatric Department B, Ha’Emek Medical Center, Afula, Israel
Rappaport Faculty of Medicine, Technion – Israel Institute of Technology, Haifa, Israel
Search for other papers by Tal Almagor in
Google Scholar
PubMed
Search for other papers by Shoshana Rath in
Google Scholar
PubMed
Search for other papers by Dan Nachtigal in
Google Scholar
PubMed
Search for other papers by Zohara Sharroni in
Google Scholar
PubMed
Rappaport Faculty of Medicine, Technion – Israel Institute of Technology, Haifa, Israel
Search for other papers by Ghadir Elias-Assad in
Google Scholar
PubMed
Search for other papers by Ora Hess in
Google Scholar
PubMed
Search for other papers by Gilad Havazelet in
Google Scholar
PubMed
Search for other papers by Yoav Zehavi in
Google Scholar
PubMed
Rappaport Faculty of Medicine, Technion – Israel Institute of Technology, Haifa, Israel
Search for other papers by Ronen Spiegel in
Google Scholar
PubMed
GGA – Galil Genetic Analysis Laboratory Ltd., Kazerin, Israel
Search for other papers by Dani Bercovich in
Google Scholar
PubMed
Search for other papers by Shlomo Almashanu in
Google Scholar
PubMed
Rappaport Faculty of Medicine, Technion – Israel Institute of Technology, Haifa, Israel
Search for other papers by Yardena Tenenbaum-Rakover in
Google Scholar
PubMed
sensorineural) among CH patients compared to the normal population, with a particularly high incidence in patients with thyroid agenesis and severe disease at diagnosis (as assessed by delayed epiphyseal ossification) [ 14 ]. In other studies, HI was associated